FINWIRES · TerminalLIVE
FINWIRES

$AHR

4 stories mentioning AHRUpdated 33d ago

Every FINWIRES story that references AHR, newest first.

Insider Trading

American Healthcare REIT Insider Sold Shares Worth $1,267,403, According to a Recent SEC Filing

Brian Peay, Chief Financial Officer, on June 26, 2026, sold 25,000 shares in American Healthcare REIT (AHR) for $1,267,403. Following the Form 4 filing with the SEC, Peay has control over a total of 153,507 common shares of the company, with 152,700 shares held directly and 807 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1632970/000119312526288614/xslF345X05/ownership.xml

$AHR
Wire

American Healthcare REIT Shares Rise After Citigroup Upgrade

American Healthcare REIT (AHR) shares rose around 3.5% in recent Tuesday trading after Citigroup upgraded the stock to buy from neutral and set a price target of $55.Trading volume stood at over 1.3 million shares compared with a daily average of about 2.5 million shares.Price: $48.85, Change: $+1.69, Percent Change: +3.57%

$AHR
Research

Citigroup Upgrades American Healthcare REIT to Buy From Neutral, Price Target is $55

American Healthcare REIT (AHR) has an average rating of buy and mean price target of $58.23, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AHR
Wire

American Healthcare REIT to Benefit From Higher Investment Pace, RBC Says

American Healthcare REIT's (AHR) 2026 funds from operations, or FFO, estimates have been raised ahead of the company's Q1 results as it is seen benefitting from a higher investment pace, RBC Capital Markets said in a note emailed Monday.RBC's 2026 FFO estimate for American Healthcare REIT is now $2.04 per share, an increase of $0.03 per share, which compares to the management's outlook range of $1.99 to 2.05 per share, the note said.The new estimates are backed by the company's higher investment pace, reflecting about $900 million of net investment activity annually, up about $350 million compared to RBC's previous estimates, the investment firm said.RBC noted, however, that this will likely be offset by "more modest" Trilogy same store net operating income, or NOI, growth, reflecting a 10% compound annual growth rate in 2026 and 2027, which is a decrease of about 200 basis points versus RBC's previous estimates.The new estimates reflect a core earnings growth rate of 18.5% this year and 15.9% next year, an outlook which is "generally supported by low-double-digit levered organic growth and mid-single-digit external growth offset by modest G&A and other leakage," the note said.American Healthcare REIT is scheduled to release its Q1 results on May 7.RBC kept American Healthcare REIT's outperform rating and $54 price target.Price: $48.38, Change: $-0.85, Percent Change: -1.73%

$AHR

Track with the FINWIRES app suite